In ADHD Play, Pfizer Inks $700M Deal For NextWave Pharma
In a wager that reflects spiking rates of childhood behavioral ailments, Pfizer Inc. said Monday it will pay up to $700 million for NextWave Pharmaceuticals Inc., which recently won regulatory approval...To view the full article, register now.
Already a subscriber? Click here to view full article